DENTSPLY SIRONA (NASDAQ:XRAY) Issues Quarterly Earnings Results

Key Points

• DENTSPLY SIRONA reported an earnings per share (EPS) of $0.52, exceeding analysts' estimates of $0.50 by $0.02, while revenue was $936 million, surpassing expectations of $929.67 million.
• The company has updated its fiscal year 2025 EPS guidance to a range of $1.800-$2.000.
• DENTSPLY SIRONA announced a quarterly dividend of $0.16 per share, equating to an annualized yield of 4.9%, with the dividend payout scheduled for October 10th.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) announced its quarterly earnings data on Thursday. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.02, Zacks reports. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%. The firm had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. During the same quarter in the prior year, the company posted $0.49 earnings per share. DENTSPLY SIRONA's quarterly revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA updated its FY 2025 guidance to 1.800-2.000 EPS.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY traded up $0.81 on Wednesday, hitting $13.86. The company had a trading volume of 1,878,927 shares, compared to its average volume of 2,987,031. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA has a 52-week low of $12.16 and a 52-week high of $27.48. The business has a 50 day moving average of $15.59 and a 200 day moving average of $15.81. The company has a market cap of $2.76 billion, a PE ratio of -2.93, a PEG ratio of 0.78 and a beta of 0.94.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.6%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio is currently -13.50%.

Analyst Ratings Changes

A number of brokerages recently weighed in on XRAY. UBS Group dropped their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Piper Sandler dropped their price objective on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. Morgan Stanley lowered DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective on the stock. in a report on Tuesday, April 15th. Wall Street Zen downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday. Finally, Barrington Research set a $18.00 target price on DENTSPLY SIRONA and gave the stock an "outperform" rating in a research report on Friday. Twelve investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA has a consensus rating of "Hold" and a consensus price target of $18.64.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Cetera Investment Advisers lifted its position in shares of DENTSPLY SIRONA by 27.5% in the second quarter. Cetera Investment Advisers now owns 27,064 shares of the medical instruments supplier's stock valued at $430,000 after acquiring an additional 5,839 shares in the last quarter. Focus Partners Wealth lifted its position in shares of DENTSPLY SIRONA by 59.1% in the first quarter. Focus Partners Wealth now owns 25,181 shares of the medical instruments supplier's stock valued at $376,000 after acquiring an additional 9,355 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in DENTSPLY SIRONA by 7.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 593,021 shares of the medical instruments supplier's stock worth $8,860,000 after buying an additional 41,579 shares during the period. Empowered Funds LLC lifted its position in DENTSPLY SIRONA by 8.8% during the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier's stock worth $244,000 after buying an additional 1,320 shares during the period. Finally, Goldman Sachs Group Inc. lifted its position in DENTSPLY SIRONA by 827.3% during the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier's stock worth $36,378,000 after buying an additional 2,172,343 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.